Detalhe da pesquisa
1.
Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19.
CPT Pharmacometrics Syst Pharmacol
; 12(4): 513-521, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36798006